VAERS Reports EN8737

VAERS 1705484

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

kritisch

Staat: MN
Alter: 68,0
Geschlecht: M
Eingang: 16.09.2021
Impfdatum: 12.03.2021
Beginn: 13.09.2021
Tage bis Beginn: 185,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Headache Myocardial infarction Oropharyngeal pain Pain Pyrexia Vascular device user

Symptomtext

The patient presents with URI symptoms for 3-4 days. Symptoms include fever, chills, cough, sore throat, headache, body aches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Hyperlipidemia. Degenerative disc disease. BPH. CAD s/p MI 8/2/21 with stent to proximal circumflex and LAD
Andere Medikamente: Prasugrel Aspirin Adult Low Dose ; Atorvastatin ; Lisinopril Metoprolol Succinate ER
Allergien: -
Vorherige Impfungen: -

VAERS 1288991

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

moderat

Staat: OR
Alter: 70,0
Geschlecht: M
Eingang: 05.05.2021
Impfdatum: 06.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Hypoaesthesia Injection site pain Motor dysfunction Muscular weakness Myalgia Pain Paraesthesia Product administered at inappropriate site

Symptomtext

Patient is a male who presents for a 1 month history of numbness, tingling and weakness of the fourth and fifth fingers of the left hand. He presents with his wife who concurs with history. He describes the numbness tingling sensation extending up his left hand into the proximal forearm and what would be the ulnar distribution. He is noted weakness of the fourth and fifth digits such that he cannot fully grasp with that hand compared to his contralateral hand. Patient describes more numbness and weakness than frank pain although he has noticed it when he is woken up at night. He has not taken any specific medication for this. Patient states this started approximately April eighth ninth or 10th several days after getting his first Pfizer vaccination in the left arm. That was a Pfizer Lot number EN 8737 expiration July 2021 given on April 6 at the urgent care vaccination site. Patient feels the vaccine was given behind his deltoid on the shoulder rather than mid deltoid muscle. He did not have any pain numbness or shooting sensations immediately. Reports the muscle was a little sore that day or the next but really nothing of significance until several days later. He did not report any significant redness or swelling at the site of the vaccination. He reports not having any photos of the side of the vaccination but he and his wife did take a photo about a week ago of the area of that he feels is still tender in the posterior shoulder region It is not clear to me whether the soreness in the shoulder extended down to the hand and then improve leaving the hand symptoms or whether soreness disappeared at the time the hand arm symptoms came on. He has not had any similar symptoms he denies having any carpal tunnel or hand problems in the past. Past medical history is pertinent for: some chronic back pain in the thoracic or lumbar region that began after traumatic vertebral fractures following a motor vehicle accident in 2012. he is followed by Dr. of pain specialist of, She is maintained on chronic methadone. He has had recent lower thoracic or lumbar block with plans to have radioablation therapy to those nerve roots in the next several days. Also has well-controlled hypertension on lisinopril 20 mg and takes 81 mg enteric-coated aspirin daily. Here for evaluation as symptoms have not resolved on their own over the last 3 to 4 weeks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: Nerve conduction studies and hand therapy pending nerve conduction studies often take 1 to 3 months in this region of the state
Aktuelle Erkrankungen: Patient with chronic thoracolumbar pain after traumatic MVA related thoracolumbar vertebral fractures from 2012. Receiving injections and radio ablative therapy to local nerves
Vorgeschichte: Chronic pain and hypertension
Andere Medikamente: Lisinopril; methadone; aspirin
Allergien: No known drug allergies
Vorherige Impfungen: -

VAERS 1811113

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

mild

Staat: IN
Alter: 52,0
Geschlecht: F
Eingang: 23.10.2021
Impfdatum: 15.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lymph node pain Lymphadenopathy

Symptomtext

Lymph nodes under arm are sore and nodes along collarbone are extremely sore.; Lymph nodes under arm are sore and nodes along collarbone are extremely sore and swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN8737) via an unspecified route of administration in the left arm on 15Apr2021 at 07:00 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. Medical history included depression. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received escitalopram (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN) and vortioxetine (MANUFACTURER UNKNOWN) for unspecified indication from unknown dates and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 16Mar2021 at 07:00 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced that lymph nodes under arm were sore and nodes along collarbone were extremely sore and swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymph node pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Depression
Andere Medikamente: WELLBUTRIN
Allergien: -
Vorherige Impfungen: -

VAERS 1198419

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

mild

Staat: HI
Alter: 44,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 03.04.2021
Beginn: 03.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Asthma Body temperature increased Diarrhoea Fatigue Nausea Oropharyngeal pain

Symptomtext

Stomach cramps, nausea, diarrhea (9 days); Elevated temperature (99+?, 4 days); sore throat (6 days); 2 asthma attacks within week following vaccine (increase from zero attacks in previous 3+ months); extreme fatigue (8 days).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Crohn's disease, asthma, eczema, psoriasis, arthritis, cyclic neutropenia.
Vorgeschichte: Crohn's disease, asthma, eczema, psoriasis, arthritis, cyclic neutropenia.
Andere Medikamente: Doxycycline, Montelukast, Allegra, vitamin d, cortisol manager (Integrative Therapeutics), naproxen sodium, Excedrin migraine.
Allergien: Corn and corn derivatives, citric acid, white vinegar, mushrooms, PCN, sulfa.
Vorherige Impfungen: Fever and body aches with flu vaccines.

VAERS 1950740

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

gering

Staat: AL
Alter: 67,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 31.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Rheumatoid arthritis

Symptomtext

Rheumatoid Arthritis flare; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 67 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 31Mar2021 (Lot number: EN8737) at the age of 67 years as dose 1, single and administered in arm right, administration date 20Apr2021 09:00 (Lot number: EN8727) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid Arthritis" (ongoing); "HTN" (unspecified if ongoing); "Aortic valve leak (minor)" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; ATORVASTATIN; OMEPRAZOLE. No other vaccine in four weeks. No covid prior vaccination, no covid tested post vaccination and no known allergies. The following information was reported: RHEUMATOID ARTHRITIS (medically significant) with onset Apr2021, outcome "recovered" (2021), described as "Rheumatoid Arthritis flare". Therapeutic measures were taken as a result of rheumatoid arthritis included Prednisone and NSAIDS. Clinical course included Rheumatoid Arthritis flare (first in 6 years; was in remission and on no maintenance meds) appropriate 9 days after first dose, 4 days after second dose. Patient was incapacitated. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rheumatoid arthritis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Rheumatoid arthritis
Vorgeschichte: Medical History/Concurrent Conditions: Aortic regurgitation; Hypertension
Andere Medikamente: METOPROLOL; ATORVASTATIN; OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 1673827

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

gering

Staat: CO
Alter: 64,0
Geschlecht: M
Eingang: 04.09.2021
Impfdatum: 02.04.2021
Beginn: 02.04.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Tinnitus; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN8737) via an unspecified route of administration in the left arm on 02Apr2021 at 13:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN208) via an unspecified route of administration in the left arm on 19Mar2021 at 13:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 13:15, the patient experienced inappropriate schedule of vaccine administered. On 05Apr2021 at 13:15, the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1666460

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

gering

Staat: CO
Alter: 58,0
Geschlecht: M
Eingang: 02.09.2021
Impfdatum: 01.04.2021
Beginn: 18.08.2021
Tage bis Beginn: 139,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Positive covid-19 test on 8/18/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1332751

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8737

gering

Staat: WA
Alter: 32,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 03.04.2021
Beginn: 04.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Deafness neurosensory Tinnitus

Symptomtext

AS sensorineural hearing loss; tinnitus; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 03Apr2021 15:00 (Lot Number: EN8737) as 2nd dose, single for covid-19 immunisation. The patient medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included bupropion hydrochloride (BUPROPION HCL XL) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of bnt162b2 (Lot number: EN6208) on 13Mar2021 15:30, administered in Left arm for covid-19 immunisation. The patient experienced Sudden AS sensorineural hearing loss likely causing tinnitus possibly related to Covid vaccination response on 04Apr2021 08:00. Event seriousness criteria was disability. The patient presented with hearing loss for 1 month, onset after COVID vaccine which was on 03Apr2021. The adverse event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Treatment received for the adverse event included two separate transtympanic steroid injections, and prednisone medication (60mg then taper). Since the vaccination, the patient has not been tested for COVID-19. The outcome of event was not recovered. Information on Lot/Batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deafness neurosensory
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: BUPROPION HCL XL
Allergien: -
Vorherige Impfungen: -